Media overview

9 Meter sessies – AFLEVERING 4
IBD management & patiënt empowerment
In de vierde en alweer de laatste aflevering van deze IBD-podcastserie gaat dr. Marjolijn Duijvestein de sportieve uitdaging aan om al fietsend met host Jeroen Jansen in gesprek te gaan over IBD-management. Want hoe houd je IBD onder controle? En wat is de rol van de patiënt in zijn of haar eigen ziekte? Dit en meer in deze laatste aflevering. Dr. Marjolijn Duijvestein, Radboud UMC
Audio
9 Meter sessies – AFLEVERING 3
Immunologie – therapeutische targets
Fanatiek fietser Prof.dr. Sander van Deventer houdt zich dagelijks bezig met het menselijk immuunsysteem en IBD. Hij gaat al fietsend in gesprek met host Jeroen Jansen over de therapeutische targets van geneesmiddelen bij IBD. Prof.dr. Sander van Deventer, Operating partner Forbion/CTO VectorY Therapeutics/CSO Portion Biologics
Audio
9 Meter sessies – AFLEVERING 2
Artificial intelligence binnen de IBD zorg
Hoe kun je zorg voor IBD-patïenten naar een hoger niveau tillen op een toekomstbestendige manier? Dat is de vraag die in de tweede aflevering centraal staat. Jeroen neemt ons al fietsend mee in het verhaal van Daan Hommes; internist MDL-arts van achtergrond, maar tegenwoordig vooral bezig met de digitale en waarde gedreven IBD-zorg van de toekomst. Prof.dr. Daniël Hommes, DEARhealth
Audio
9 Meter sessies – AFLEVERING 1
Wetenschappelijk onderzoek – proctitis
In deze eerste aflevering gaat Jeroen Janssen in gesprek met MDL-arts Pieter Stokkers over wetenschappelijk onderzoek binnen IBD en praten ze over proctitis. Benieuwd? Luister nu! Dr. Pieter Stokkers, OLVG
Audio
How Covid19 is affecting other respiratory infections?

Speaker: Prof. Marc Van Ranst - Director Clinical and Epidemiological Virology Unit Rega Institute for Medical Research - University of Leuven, Head of Laboratory Medicine - University Hospitals Leuven

Video
Vaccine hesitancy: lessons learned in Europe

Speaker: Prof. dr. ir. Alex Vorsters - University of Antwerp, Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute

Video
Tailored Vaccination strategies-providing the right vaccination strategy for the individual patient

Speaker: Prof. dr. Eric van Gorp - Internist/infectiologist/virologist, Erasmus MC Rotterdam

Video
Mode of Action video - Tremfya in PsA

Tremfya is the first approved fully human monoclonal antibody that selectively binds to the p19 subunit of interleukin (IL)-23 and inhibits its interaction with the IL-23 receptor.[1]

Tremfya PsA
Video
The Bird trial is a Belgian Real-world study
The Bird trial is a Belgian Real-world study where 334 patients with Chronic lymphocytic leukemia, Mantle Cell lymphoma or Waldenstrom Macroglobulinemia are being treated with Ibrutinib.
Imbruvica
Audio
Prof. Philippe Moreau presents the results of part 1 of the CASSIOPEIA study
Philippe Moreau of University Hospital Hôtel-Dieu 02 September 2019 CASSIOPEIA STUDY
Video
Is precision treatment of KRAS mutant NSCLC advancing? What is the best strategy?
Prof. Dr. I. Demedts, AZ Delta, Roeselare
Dr. A. Sibille, CHU de Liège
Dr. L. Pirard, CHU UCL Namur, Godinne
Video
What lies beyond the osimertinib horizon?
Dr. C. De Bondt, Universitair Ziekenhuis Antwerpen
Prof. Dr. J. Vansteenkiste, Universitair Ziekenhuis Leuven
Dr. L. Van Den Bosch, Universitair Ziekenhuis Antwerpen
Video
Is there a place for chemo- and immunotherapy combination in patients with high PD-L1 expression?
Dr. K. Cuppens, Jessaziekenhuis, Hasselt
Prof. Dr. K. Vermaelen, Universitair Ziekenhuis Gent
Dr. B. Forier, Universitair Ziekenhuis Leuven
Video
Is there a place for immunotherapy for tumors with oncogenic driver mutations?
Prof. Dr. T. Berghmans, Institut Jules Bordet, Bruxelles
Dr. F. Aboubakar Nana, Cliniques Universitaires St-Luc, Bruxelles
Dr. M. Brandao, Institut Jules Bordet, Bruxelles
Video
Immunology-Meded-Rheumatology-Podcasts-Part1
Rheumatology in 2030 - part 1:
The future of rheumatology looks promising. In part 1 of this two-part, visionary podcast series "Rheumatology in 2030", Prof. Dr. Dirk Elewaut (UZ Gent) and Prof. Dr. Margreet Kloppenburg (Leiden University Medical Center) look ahead to the next 10 years of their specialism with a lot of optimism.
Rheumatology
Audio
Immunology-Meded-Rheumatology-Podcasts-Part2
Rheumatology in 2030 - part 2
More adminstrative tasks and less time for qualitative interactions with your patients. Will this be the future of rheumatology? Preferrably not! In part 2 of this two-part, visionary podcast series "Rheumatology in 2030", Prof. Dr. Dirk Elewaut (UZ Gent) and Prof. Dr. Margreet Kloppenburg (Leiden University Medical Center) share their views on how technological advancements could allow you to spend more time with your patients, but also how the ever changing healthcare system might look like.
Rheumatology
Audio
Highlights of EULAR 2021
During this webcast, the faculty provides an update on the newest developments in the field of rheumatology that were presented at EULAR 2021 (2-5 June 2021).
Rheumatology
Immunology
Video
One year on: an update on imid management during the pandemic
This webinar addresses issues that healthcare providers may face when they treat patients with immune-mediated inflammatory diseases (IMIDs) during the COVID-19 pandemic.
Gastroenterology
Immunology
Video
Highlights of AAD VMX 2021
This webinar provides an update on the newest developments in the field of inflammatory skin diseases that were presented at AAD VMX 2021 (23-25 April 2021).
Dermatology
Immunology
Video
Early biologic treatment in Crohn's disease: shining a light on seavue
Matthieu Allez (France)
Silvio Danese (Italy)
Peter Irving (UK)
Gastroenterology
Immunology
Video
One year on: an update on IMID management during the pandemic
This webinar addresses issues that healthcare providers may face when they treat patients with immune-mediated inflammatory diseases (IMIDs) during the COVID-19 pandemic.
Immunology